June 23, 2020 / 5:06 AM / 19 days ago

BRIEF-Cosmo Pharmaceuticals Announces Regulatory Approval Of Gi Genius In Israel

June 23 (Reuters) - COSMO PHARMACEUTICALS NV:

* ANNOUNCES REGULATORY APPROVAL OF GI GENIUS™ IN ISRAEL

* TRIAL REQUIRED FOR GI GENIUS™ REGISTRATION IN U.S. WHICH COMMENCED EARLIER THIS YEAR AND WHICH WAS SUBSTANTIALLY HALTED DUE TO COVID-19 IS NOW RESUMING

* TRIAL IS EXPECTED TO LAST APPROXIMATELY 4-6 MONTHS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below